RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 43,511 Value ($000) $246 Avg Close $4.95 Range $3.81 - $7.18

Q4 2024

Shares 32,755 Value ($000) $221 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 32,755 Value ($000) $216 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 32,755 Value ($000) $246 Avg Close $8.72 Range $6.75 - $10.66

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	43,511	$246	$4.95	$3.81 - $7.18
Q4 2024	32,755	$221	$6.72	$5.60 - $9.55
Q3 2024	32,755	$216	$7.17	$5.88 - $8.73
Q2 2024	32,755	$246	$8.72	$6.75 - $10.66